Valuation: Biogen Inc.

Market Cap 29.55B 25.98B 24.18B 22.21B 41.7B 2,834B 42.25B 287B 112B 1,399B 111B 109B 4,836B P/E 2026 *
24.8x
P/E 2027 * 15.9x
Enterprise Value 34.18B 30.04B 27.97B 25.68B 48.23B 3,277B 48.86B 332B 130B 1,618B 128B 126B 5,593B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.1x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+1.20%
1 week-0.14%
Current month-6.10%
1 month-6.35%
3 months+10.63%
6 months+16.04%
Current year+15.27%
1 week 196.92
Extreme 196.915
204.47
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 124.56
Extreme 124.5561
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 13/11/2022
Director of Finance/CFO 60 28/02/2025
Chief Tech/Sci/R&D Officer - 31/12/2020
Director TitleAgeSince
Director/Board Member 69 22/03/2010
Director/Board Member 77 31/12/2009
Director/Board Member 72 18/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06/26 Free

Director

1,505 0.0010%
09/06/26 Free

Director

1,505 0.0010%
09/06/26 Free

Director

1,505 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-0.14%+56.92%-23.51% 29.55B
+2.96%+1.82%+23.07%-7.86% 67.88B
+1.79%+2.58%+39.89%+213.85% 53.23B
+0.26%+54.90%+54.90%+54.90% 48.71B
+2.69%-2.52%-55.39%-55.35% 38.98B
+5.19%+8.95%+82.30%+102.73% 23.75B
-1.55%-8.46%+61.04%-53.98% 22.07B
+0.62%-2.81%+0.84%+162.10% 19.84B
+0.60%+0.39%+65.65%+126.60% 16.57B
-0.20%+2.00%+81.91%+144.32% 16.49B
Average +1.35%+0.77%+41.11%+66.38% 33.71B
Weighted average by Cap. +1.65%+1.44%+34.54%+58.18%

Financials

2026 *2027 *
Net sales 10.07B 8.85B 8.24B 7.57B 14.21B 966B 14.4B 97.94B 38.25B 477B 37.8B 36.98B 1,648B 10.32B 9.07B 8.45B 7.76B 14.57B 990B 14.76B 100B 39.21B 489B 38.75B 37.91B 1,689B
Net income 1.29B 1.13B 1.05B 969M 1.82B 124B 1.84B 12.54B 4.9B 61.04B 4.84B 4.73B 211B 1.99B 1.75B 1.63B 1.49B 2.8B 190B 2.84B 19.32B 7.55B 94.06B 7.46B 7.3B 325B
Net Debt 4.63B 4.07B 3.79B 3.48B 6.53B 444B 6.62B 45.01B 17.58B 219B 17.37B 17B 757B 2.46B 2.16B 2.01B 1.85B 3.47B 236B 3.52B 23.92B 9.34B 116B 9.23B 9.03B 402B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
28/07/26 US$202.88 +1.37% 314,036
27/07/26 US$200.14 -1.01% 762,581
24/07/26 US$202.19 +0.78% 596,372
23/07/26 US$200.62 +1.46% 1,032,070
22/07/26 US$197.74 -2.67% 841,350
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
200.14USD
Average target price
228.26USD
Spread / Average Target
+14.05%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock